Study investigates proton radiation effects on cells

August 5, 2012 in Cancer

(Phys.org) -- A team of researchers at NASA's Johnson Space Center in Houston and Lawrence Berkeley National Laboratory in Berkeley, Calif., has found radiation from protons could further enhance a process that occurs during tumor progression. This information may help lead to better methods to protect astronauts from the harmful effects of radiation in space, as well as help cancer researchers on Earth better understand the effects of radiation treatment on the human body.

NASA is particularly interested in this research because protons, which are charged , are the main source of space radiation astronauts receive during spaceflights. The study was part of NASA's ongoing effort to learn how to mitigate the effects of radiation during long-duration missions to destinations beyond , such as asteroids and Mars.

"Our paper makes new discoveries on the potential risks from low doses of protons that occur outside of the tumor during radiation therapy, and to all tissues for astronauts exposed to space radiation," said Francis A. Cucinotta, chief scientist for the Human Research Program Space Radiation Program Element at Johnson and one of the authors of the paper.

The objective of the researchers was to study the biological effects of low-energy protons on epithelial cells (membranous tissues found throughout the body) and the protons' propensity to enhance a process that occurs during . This process is called epithelial-mesenchymal transition (EMT), which has been associated with . EMT also has been linked to radiation-induced fibrosis, one of the most common late effects of radiotherapy.

Notably, the study revealed protons alone can induce EMT-associated changes in normal human epithelial cells. Although the total body dose received in space is moderately low compared to what is received in radiotherapy, this study reveals that low doses of protons still may prompt EMT and result in potentially detrimental effects.

These studies were conducted at Johnson and at the NASA Laboratory at Brookhaven National Laboratory, Upton, N.Y.

Results of the study were published as "Protons Sensitize Epithelial Cells to Mesenchymal Transition" in the July 23 issue of the journal PLoS ONE.

More information: dx.plos.org/10.137… pone.0041249

Journal reference: PLoS ONE search and more info website

Provided by NASA search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

New fluorescent tools for cancer diagnosis

In recent years, microRNAs (miRNAs) and other non-coding RNAs are small molecules that help control the expression of specific proteins. In recent years they have emerged as disease biomarkers. miRNA profiles have been used ...

Cancer created May 24, 2013 | popularity not rated yet | comments 0

Modulating the immune system to combat metastatic cancer

Cancer cells spread and grow by avoiding detection and destruction by the immune system. Stimulation of the immune system can help to eliminate cancer cells; however, there are many factors that cause the immune system to ...

Cancer created May 24, 2013 | popularity 5 / 5 (1) | comments 0

Scientists put bowel cancer under the microscope

Researchers from London's Kingston University have begun a two-year study which could help prolong the lives of people with colorectal tumours.

Cancer created May 24, 2013 | popularity 5 / 5 (1) | comments 0

Researcher identifies breast cancer fighting hormone

Transformative research from Western University has identified new hormones in the body which may suppress breast cancer and stimulate the regression of breast tumors.

Cancer created May 24, 2013 | popularity 5 / 5 (2) | comments 0

Ground breaking cancer research finds immune system link

(Medical Xpress)—Curtin University researchers have found evidence that targeting specific cells in the body can reverse the effects of cancer on the immune system.

Cancer created May 24, 2013 | popularity 5 / 5 (4) | comments 0


First drug to improve heart failure mortality in over a decade

Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...

Seniors more likely to crash when driving with pet, study finds

(HealthDay)—Animals make great companions for senior citizens, but elderly people who always drive with a pet in the car are far more likely to crash than those who never drive with a pet, researchers have ...

Heart failure accelerates male 'menopause'

Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...

Death highest in heart failure patients admitted in January, on Friday, and overnight

Mortality and length of stay are highest in heart failure patients admitted in January, on Friday, and overnight, according to research presented today at the Heart Failure Congress 2013. The analysis of nearly 1 million ...

Feds fight morning-after pill age ruling in NY

(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...

New immune system discovered

(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.